This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Dufau, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Dufau, M. L.

Next Article 

Molecular and Cellular Biology, September 2005, p. 7929-7939, Vol. 25, No. 18
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.18.7929-7939.2005

Coordinated Changes in DNA Methylation and Histone Modifications Regulate Silencing/Derepression of Luteinizing Hormone Receptor Gene Transcription

Ying Zhang, Naheed Fatima, and Maria L. Dufau*

Section on Molecular Endocrinology, Endocrinology and Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892

Received 25 January 2005/ Returned for modification 10 March 2005/ Accepted 27 June 2005

We have previously demonstrated that transcription of the luteinizing hormone receptor (LHR) gene is subject to repression by histone deacetylation at its promoter region, where a histone deacetylase (HDAC)/mSin3A complex is anchored at a proximal Sp1 site. The present studies have shown that epigenetic silencing and activation of the LHR gene is achieved through coordinated regulation at both the histone and DNA levels. The HDAC inhibitor trichostatin A (TSA) evoked robust but significantly lower activation of the LHR gene in JAR than in MCF-7 cells. This effect was localized to the 176-bp promoter region, which is highly methylated in JAR and lightly methylated in MCF-7 cells. Consequently, TSA and the DNA demethylating reagent 5-azacytidine (5-AzaC) caused marked synergistic activation of the LHR gene in JAR but not in MCF-7 cells. Multiple site-specific lysine acetylation of H3/H4 is associated with such LHR gene activation. Methylation or acetylation of H3 at K9 is present at the silenced and derepressed LHR promoter, respectively. While DNA methylation levels did not affect the histone code of the LHR gene promoter, demethylation of the promoter CpG sites was necessary for maximal stimulation of this gene. Mechanistically, the combined actions of TSA and 5-AzaC, but not either 5-AzaC or TSA alone, resulted in complete demethylation of the LHR gene promoter in JAR cells. Release of the repressive HDAC/mSin3A complex from the LHR gene promoter in both cell types required both TSA-induced changes of histone modifications and, concurrently, a demethylated promoter. Also, Dnmt1 was largely dissociated from the LHR gene promoter in the presence of TSA or TSA plus 5-AzaC, and binding of MBD2 in JAR cells was diminished upon conversion of the promoter to a demethylated state. Such changes induced a more permissive chromatin where recruitment of polymerase II and TFIIB to the promoter was significantly increased. The activated state of the LHR gene induced by TSA and 5-AzaC in JAR and MCF-7 cells was observed basally in LHR-expressing PLC cells, in which the promoter is unmethylated and associated with hyperacetylated histones. Consequently, PLC cells are unresponsive to drug treatment. These findings have elucidated a regulatory mechanism whereby concurrent dissociation of repressors and association of activators and basal transcriptional components, resulting from coordinated histone hyperacetylation and DNA demethylation, lead to derepression of the LHR gene expression.

* Corresponding author. Mailing address: ERRB, NICHD, National Institutes of Health, Bldg. 49, Rm. 6A-36, 49 Convent Dr., MSC 4510, Bethesda, MD 20892-4510. Phone: (301) 496-2021. Fax: (301) 480-8010. E-mail: dufaum{at}mail.nih.gov.

Molecular and Cellular Biology, September 2005, p. 7929-7939, Vol. 25, No. 18
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.18.7929-7939.2005




This article has been cited by other articles:

  • Brunner, A. L., Johnson, D. S., Kim, S. W., Valouev, A., Reddy, T. E., Neff, N. F., Anton, E., Medina, C., Nguyen, L., Chiao, E., Oyolu, C. B., Schroth, G. P., Absher, D. M., Baker, J. C., Myers, R. M. (2009). Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res 19: 1044-1056 [Abstract] [Full Text]  
  • Han, D. W., Do, J. T., Arauzo-Bravo, M. J., Lee, S. H., Meissner, A., Lee, H. T., Jaenisch, R., Scholer, H. R. (2009). Epigenetic Hierarchy Governing Nestin Expression. Stem Cells 27: 1088-1097 [Abstract] [Full Text]  
  • Zhang, Y., Liao, M., Dufau, M. L. (2008). Unlocking Repression of the Human Luteinizing Hormone Receptor Gene by Trichostatin A-induced Cell-specific Phosphatase Release. J. Biol. Chem. 283: 24039-24046 [Abstract] [Full Text]  
  • Fejer, G., Koroknai, A., Banati, F., Gyory, I., Salamon, D., Wolf, H., Niller, H. H., Minarovits, J. (2008). Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus. J. Gen. Virol. 89: 1364-1370 [Abstract] [Full Text]  
  • Liao, M., Zhang, Y., Dufau, M. L. (2008). Protein Kinase C{alpha}-Induced Derepression of the Human Luteinizing Hormone Receptor Gene Transcription through ERK-Mediated Release of HDAC1/Sin3A Repressor Complex from Sp1 Sites. Mol. Endocrinol. 22: 1449-1463 [Abstract] [Full Text]  
  • Li, D., Da, L., Tang, H., Li, T., Zhao, M. (2008). CpG methylation plays a vital role in determining tissue- and cell-specific expression of the human cell-death-inducing DFF45-like effector A gene through the regulation of Sp1/Sp3 binding. Nucleic Acids Res 36: 330-341 [Abstract] [Full Text]  
  • Schnekenburger, M., Talaska, G., Puga, A. (2007). Chromium Cross-Links Histone Deacetylase 1-DNA Methyltransferase 1 Complexes to Chromatin, Inhibiting Histone-Remodeling Marks Critical for Transcriptional Activation. Mol. Cell. Biol. 27: 7089-7101 [Abstract] [Full Text]  
  • Michelotti, G. A., Brinkley, D. M., Morris, D. P., Smith, M. P., Louie, R. J., Schwinn, D. A. (2007). Epigenetic regulation of human {alpha}1d-adrenergic receptor gene expression: a role for DNA methylation in Sp1-dependent regulation. FASEB J. 21: 1979-1993 [Abstract] [Full Text]  
  • Dokras, A., Coffin, J., Field, L., Frakes, A., Lee, H., Madan, A., Nelson, T., Ryu, G.-Y., Yoon, J.-G., Madan, A. (2006). Epigenetic regulation of maspin expression in the human placenta. Mol Hum Reprod 12: 611-617 [Abstract] [Full Text]  
  • Zhang, Y., Liao, M., Dufau, M. L. (2006). Phosphatidylinositol 3-Kinase/Protein Kinase C{zeta}-Induced Phosphorylation of Sp1 and p107 Repressor Release Have a Critical Role in Histone Deacetylase Inhibitor-Mediated Depression of Transcription of the Luteinizing Hormone Receptor Gene.. Mol. Cell. Biol. 26: 6748-6761 [Abstract] [Full Text]  
  • Honda, H., Pazin, M. J., Ji, H., Wernyj, R. P., Morin, P. J. (2006). Crucial Roles of Sp1 and Epigenetic Modifications in the Regulation of the CLDN4 Promoter in Ovarian Cancer Cells. J. Biol. Chem. 281: 21433-21444 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»